AIM ImmunoTech Inc. (AIM) Financials
Stock symbol AIM is outdated, potentially delisted? Maybe it is available on other exchange?
AIM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 8.6 million | 9.9 million |
| Sept. 30, 2024 | 13.6 million | 10.7 million |
| June 30, 2024 | 15.7 million | 9.6 million |
| March 31, 2024 | 16.2 million | 11.4 million |
AIM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | -4.1 million | 196000 |
| Sept. 30, 2024 | -3.3 million | 330000 |
| June 30, 2024 | -3.2 million | 80000 |
| March 31, 2024 | -4.9 million | 80000 |
AIM Net Income
No data available :(
AIM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 4.0 million | 395000 | 634000 |
| Sept. 30, 2024 | 7.2 million | 576000 | 669000 |
| June 30, 2024 | 10.1 million | 771000 | 722000 |
| March 31, 2024 | 10.9 million | 1.5 million | 777000 |
AIM Shares Outstanding
AIM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | 119000 | 1.7 million | 4.2 million | - |
| Sept. 30, 2024 | 158000 | 1.4 million | 3.1 million | - |
| June 30, 2024 | 229000 | 1.1 million | 2.6 million | 61000 |
| March 31, 2024 | 50000 | 2.0 million | 3.8 million | -58000 |
AIM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | 45000 | 7000 |
| Sept. 30, 2024 | 35000 | 8000 |
| June 30, 2024 | 50000 | 8000 |
| March 31, 2024 | 40000 | 66000 |
AIM Revenue by Segment
Graph available only for paid members. Upgrade to see it.
AIM
Price: $0.09
52 week price:
Earnings Per Share: -0.31 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 36383
Market Capitalization: 6.5 million